Combination PET-MRI scanner expands imaging frontiers
p, ,
{margin:0in;margin-bottom:.0001pt;font-size:12.0pt;font-family:Cambria;}
.t
{font-size:10.0pt;font-family:Cambria;}
@page WordSection1
{size:8.5in 11.0in;margin:1.0in 1.25in 1.0in 1.25in;}
div.WordSection1
{page:WordSection1;}
Scientists at Washington University School of Medicine are using a new imaging device that simultaneously performs positron-emission tomography (PET) and magnetic resonance imaging (MRI) scans, producing more detailed images than either technique alone. The scanner’s power and versatility will enable
many wonderful applications in areas ranging from cancer to neurological
disorders to heart and lung disease.
Cells talk more in areas Alzheimer’s hits first, boosting plaque component
Higher levels of cellular chatter boosts levels of amyloid beta in the brain regions that Alzheimer’s hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer’s. The finding may help explain why areas that are most active when the brain rests are often among the first to develop these plaques, according to the researchers.
Washington People: Jack Engsberg
Jack Engsberg, PhD, took his love of track and field into a study of movement that helps people with cerebral palsy regain mobility. He uses video games as therapy and has been working to teach therapists to create customized games for clients.
Symposium marks research center opening
The Intellectual and Developmental Disabilities Research Center at Washington University will hold an opening celebration symposium Tuesday, March 1.
Finding may help prevent vision loss in tumor disorder
Nerve cells in the body and brain react in opposite ways to the loss of a protein linked to a childhood tumor syndrome, researchers at Washington University School of Medicine in St. Louis have found. The finding could be important to efforts to preserve the vision of patients with neurofibromatosis 1, a genetic condition that increases risk of benign and malignant brain tumors.
Goate appointed director of Hope Center for Neurological Disorders
Alison Goate, PhD, has been named director of the Hope Center for Neurological Disorders, a partnership between Washington University School of Medicine in St. Louis and Hope Happens, a nonprofit foundation that supports research into neurodegenerative disorders.
Three medical school faculty to be honored by Academy of Science of St. Louis
Three faculty members of the School of Medicine will be honored by the Academy of Science of St. Louis: Randall Bateman, M. Carolyn Baum and Alan L. Schwartz.
$3.8 million NIH grant funds WUSTL brain imaging center
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $3.8 million grant from the National Institute of Neurological Disorders and Stroke to renew a center that helps researchers collect and use data on the brain and central nervous system.
Retired NFL players being treated by WUSTL neurologists
Washington University neurologists at Barnes-Jewish Hospital will be part of a new neurological care program for retired professional football players.
Pediatric strokes surprise parents
Stroke is commonly thought of as a concern only for older adults, but pediatric strokes annually affect 13 of every 100,000 U.S. children. In the St. Louis area, many of these patients are seen by Washington University specialists at the Pediatric Stroke Center at St. Louis Children’s Hospital.
View More Stories